Royalty Pharma plc
RPRX
$60.85
-$1.07-1.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.88M | 294.69M | 214.21M | 288.22M | 32.18M |
| Total Depreciation and Amortization | 1.29M | 1.17M | 1.20M | 1.28M | 1.38M |
| Total Amortization of Deferred Charges | 7.73M | 7.67M | 7.54M | 7.84M | 7.97M |
| Total Other Non-Cash Items | -199.99M | -420.48M | -360.43M | -426.21M | -453.76M |
| Change in Net Operating Assets | 901.55M | 835.18M | 964.64M | 831.48M | 776.22M |
| Cash from Operations | 728.46M | 718.23M | 827.15M | 702.62M | 363.98M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -226.00K | -74.19M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -229.72M | -477.87M | -847.80M | -958.09M | -237.79M |
| Cash from Investing | -229.72M | -477.87M | -847.80M | -958.31M | -311.98M |
| Total Debt Issued | -- | -- | 0.00 | 3.23B | -- |
| Total Debt Repaid | -- | -- | 0.00 | -2.28B | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -44.64M | -50.10M | -80.54M | -146.49M | -291.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -104.92M | -104.49M | -94.34M | -95.31M | -93.24M |
| Other Financing Activities | -123.59M | -118.08M | -124.72M | -149.94M | -123.00M |
| Cash from Financing | -273.15M | -272.67M | -299.60M | 562.74M | -507.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.59M | -32.30M | -320.25M | 307.04M | -455.81M |